NM_000548.5(TSC2):c.1819G>A (p.Ala607Thr) AND Tuberous sclerosis 2

Germline classification:: Benign/Likely benign (3 submissions)
Last evaluated:: Feb 1, 2024
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000989422.13

Allele description [Variation Report for NM_000548.5(TSC2):c.1819G>A (p.Ala607Thr)]

NM_000548.5(TSC2):c.1819G>A (p.Ala607Thr)

Gene:

TSC2:TSC complex subunit 2 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

16p13.3

Genomic location:

Preferred name:

NM_000548.5(TSC2):c.1819G>A (p.Ala607Thr)

Other names:

p.A607T:GCG>ACG

HGVS:

NC_000016.10:g.2070558G>A
NG_005895.1:g.26253G>A
NM_000548.5:c.1819G>AMANE SELECT
NM_001077183.3:c.1819G>A
NM_001114382.3:c.1819G>A
NM_001318827.2:c.1708G>A
NM_001318829.2:c.1672G>A
NM_001318831.2:c.1219G>A
NM_001318832.2:c.1852G>A
NM_001363528.2:c.1819G>A
NM_001370404.1:c.1819G>A
NM_001370405.1:c.1819G>A
NM_021055.3:c.1819G>A
NP_000539.2:p.Ala607Thr
NP_001070651.1:p.Ala607Thr
NP_001107854.1:p.Ala607Thr
NP_001305756.1:p.Ala570Thr
NP_001305758.1:p.Ala558Thr
NP_001305760.1:p.Ala407Thr
NP_001305761.1:p.Ala618Thr
NP_001350457.1:p.Ala607Thr
NP_001357333.1:p.Ala607Thr
NP_001357334.1:p.Ala607Thr
NP_066399.2:p.Ala607Thr
LRG_487t1:c.1819G>A
LRG_487:g.26253G>A
NC_000016.9:g.2120559G>A
NM_000548.3:c.1819G>A
NM_000548.4:c.1819G>A
P49815:p.Ala607Thr
p.A607T
p.(Ala607Thr)

Protein change:

A407T

Links:

Tuberous sclerosis database (TSC2): TSC2_00008; UniProtKB: P49815#VAR_005649; dbSNP: rs45517203

NCBI 1000 Genomes Browser:

rs45517203

Molecular consequence:

NM_000548.5:c.1819G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001077183.3:c.1819G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001114382.3:c.1819G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001318827.2:c.1708G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001318829.2:c.1672G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001318831.2:c.1219G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001318832.2:c.1852G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001363528.2:c.1819G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001370404.1:c.1819G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001370405.1:c.1819G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_021055.3:c.1819G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Tuberous sclerosis 2 (TSC2)
Identifiers:: MONDO: MONDO:0013199; MedGen: C1860707; Orphanet: 805; OMIM: 613254

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000262359	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Benign (Feb 1, 2024)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]
SCV001139745	Mendelics	criteria provided, single submitter (Mendelics Assertion Criteria 2017)	Likely benign (May 28, 2019)	unknown	clinical testing	Citation Link,
SCV002041390	Genome-Nilou Lab	criteria provided, single submitter (ACMG Guidelines, 2015)	Benign (Nov 7, 2021)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000262359

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Benign
(Feb 1, 2024)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001139745

Mendelics

criteria provided, single submitter

(Mendelics Assertion Criteria 2017)

Likely benign
(May 28, 2019)

unknown

clinical testing

Citation Link,

SCV002041390

Genome-Nilou Lab

criteria provided, single submitter

(ACMG Guidelines, 2015)

Benign
(Nov 7, 2021)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing
not provided	unknown	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing
not provided	germline	no	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000262359.12

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From Mendelics, SCV001139745.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	unknown	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From Genome-Nilou Lab, SCV002041390.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	no	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Oct 20, 2024

ClinVar

Relating variation to medicine